Tue, Mar 19, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Other Voices: Hedge fund tales - or what is wrong with merger arbitrage

Friday, November 14, 2014

amb
Alex Gavrish
This article was authored by Alex Gavrish, founder and CEO of Etalon Investment Research, and author of "Wall Street Back To Basics."

Hedge funds lose after Shire plc deal is cancelled

On October 20th, 2014, AbbVie Inc and Shire plc announced that they had agreed to terminate their proposed merger. The main reasons for cancellation were the adverse tax changes that would destroy the financial benefits of the transaction. According to agreement between companies, AbbVie will have to pay Shire a break-up fee of $1.64 billion. As widely reported in the financial media, investors gasped at the estimated losses a few hedge funds experienced, Paulson & Co being the main one among them. According to media reports, his funds held a 4.7% stake in Shire, and suffered losses of about $783 million as of October 15th, 2014. Without blinking an eye, on October 20th, Paulson’s hedge fund announced its proposal that Allergan should buy Shire if AbbVie no longer wants it. As simple as this. Paul Singer, manager of hedge fund firm Elliott Management, who is also believed to own a large stake, is considering suing AbbVie for killing the merger with Shire. And just in case this will not work, some hedge funds hav......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1